Company News in the Life Science Industry

»

Reset 

Media Advisory: Top Smoking Cessation Experts Meet in Ottawa

Read more ››
By: Nasdaq / GlobenewsWire - 19 Jan 2019
Related companies:  University of Ottawa Heart Institute

Study Helps Pharmaceutical Industry Navigate Shifting Landscape of Combination Product Development

CHAPEL HILL, N.C., Jan. 18, 2019 /PRNewswire/ -- The pharma industry recognizes the potential value of attacking complex diseases such as cancer through new therapies that utilize combinations of FDA-approved products.

Read more ››
By: PR Newswire Association LLC. - 19 Jan 2019

Testosterone Replacement Therapy In New Jersey Offered By Healthy Aging Medical Centers

WEST ORANGE, N.J., Jan. 18, 2019 /PRNewswire/ -- Healthy Aging Medical Centers is pleased to announce it now... Read more ››

By: PR Newswire Association LLC. - 19 Jan 2019

Lilly Phase 3 REACH-2 Trial Data Published in The Lancet Oncology Shows Improvement in Overall Survival with CYRAMZA® (ramucirumab) in Second-Line AFP-High Hepatocellular Carcinoma Patients

INDIANAPOLIS, Jan. 18, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced that results from the global Phase 3 REACH-2 study of CYRAMZA(®) (ramucirumab) as a single agent in the second-line treatment of people with AFP-High (alpha-fetoprotein >=400 ng/mL) hepatocellular carcinoma... Read more ››

By: PR Newswire Association LLC. - 19 Jan 2019
Related companies:  Eli Lilly and Company

CorVel Announces Promotion of Michael Combs to Chief Executive Officer

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jan 2019

Avivagen Announces TSX Venture Exchange Approval for Extension of Warrants

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jan 2019
Related companies:  Avivagen Inc.

AVROBIO, Inc. Announces Acceptance of Investigational New Drug (IND) Application for Investigator-Sponsored Phase 1/2 Clinical Trial for AVR-RD-04 Gene Therapy for Cystinosis

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jan 2019
Related companies:  Avrobio Inc.

Amicus Therapeutics Announces Presentations and Posters at 15th Annual WORLDSymposium™ 2019

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jan 2019
Related companies:  Amicus Therapeutics, Inc.

KemPharm Presenting Four Scientific Posters at APSARD's 2019 Annual Meeting

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jan 2019
Related companies:  KemPharm, Inc.

Aleafia Health Completes Strategic Investment in Australia’s CannaPacific Pty Limited

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jan 2019

TYME’s Novel Metabolic-Based Cancer Therapy, SM-88, Improves Survival in Phase II Study of Patients with Advanced Pancreatic Cancer

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jan 2019
Related companies:  Tyme Technologies, Inc.

CTD Announces Partnership with United BioSource LLC (UBC) to support the Extension Protocol for its Phase I Clinical Trial in the United States

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jan 2019

Bio-Path Holdings Announces 1-for-20 Reverse Stock Split

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jan 2019
Related companies:  Bio-Path Holdings, Inc.

Media Advisory: Top Smoking Cessation Experts Meet in Ottawa

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jan 2019
Related companies:  University of Ottawa Heart Institute

Aura Enters PR Campaign in Western Canada & Grants Options to Director

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jan 2019

EDAP TMS SA : EDAP Announces the Purchase of Focal One® HIFU by Maimonides Medical Center, Brooklyn, NY

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jan 2019
Related companies:  EDAP TMS S.A.

Micron Waste Secures Key Patents As It Looks to Cannabis and Beyond-- CFN Media

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jan 2019

Yield Growth Expands Innovative Topicals Line into Oregon -- CFN Media

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jan 2019

Precision Therapeutics Receives $1,370,000 Investment from CEO and Director, Carl Schwartz

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jan 2019
Related companies:  Precision Therapeutics Inc.

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

Read more ››
By: Nasdaq / GlobenewsWire - 18 Jan 2019
Related companies:  FIT Biotech Oy
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies